Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA) by Tsutsumi, Toshihito et al.
熊本大学学術リポジトリ
Kumamoto University Repository System
Title Evaluation of polyamidoamine dendrimer/?-
cyclodextrin conjugate (generation 3, G3) as a
novel carrie?
Author(s)Tsutsumi, Toshihito; Hirayama, Fumitoshi; Uekama,
Kaneto; Arima, Hidetoshi
CitationJournal of Controlled Release, 119(3): 349-359
Issue date2007-06-22
Type Journal Article
URL http://hdl.handle.net/2298/9109
Right
 
JCR-D-06-00851R2 
 
 
 
 
Evaluation of polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) 
as a novel carrier for small interfering RNA (siRNA) 
 
Toshihito Tsutsumi1, Fumitoshi Hirayama2, Kaneto Uekama2, and Hidetoshi Arima1,3
 
1Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1, 
Oe-honmachi, Kumamoto 862-0973, Japan, 2Faculty of Pharmaceutical Sciences, Sojo 
University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan. 
 
 
3Corresponding author. Tel: +81-96-371-4168, Fax: +81-96-371-4420,  
E-mail address: arimah@gpo.kumamoto-u.ac.jp (H. Arima) 
 
 
 
 1
ABSTRACT 
As the first step toward an evaluation of the potential use of the PAMAM dendrimer 
(G3) conjugate with α-cyclodextrin (α-CDE) for a small interfering RNA (siRNA) 
carrier, the ternary complexes of α-CDE or the transfection reagents such as 
LipofactamineTM2000 (L2), TransFastTM (TF) and LipofectinTM (LF) with plasmid DNA 
(pDNA) and siRNA were prepared, and their RNAi effects, cytotoxicity, 
physicochemical properties and intracellular distribution were compared.  Here the 
pGL2- control vector (pGL2) and pGL3-control vector (pGL3) encoding the firefly 
luciferase gene and the two corresponding siRNAs (siGL2 and siGL3) were used.  The 
ternary complexes of pGL3/siGL3/α-CDE showed the potent RNAi effects with 
negligible cytotoxicity compared to those of the transfection reagents in various cells.  
α-CDE strongly interacted with both pDNA and siRNA, and suppressed siRNA 
degradation by serum, compared to those of the transfection reagents.  α-CDE allowed 
fluorescent labeled siRNA to distribute in cytoplasm, whereas the transfection reagents 
resided in both nucleus and cytoplasm in NIH3T3 cells.  Furthermore, the binary 
complex of siRNA/α-CDE provided the significant RNAi effect in NIH3T3 cells 
transiently and stably expressing luciferase gene.  These results suggest that α-CDE 
may be utilized as a novel carrier for siRNA. 
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 2
1. Introduction 
RNA interference (RNAi) is mRNA degradation mediated by double stranded RNA 
molecules (small interfering RNAs, siRNAs) 21-27 nucleotides in length, which are 
intracellularly generated from long endogenous or exogenous double-stranded RNAs 
(dsRNAs) or directly transfected into cells [1,2].  Powerful tools for a gene function 
study and RNAi therapy are emerging as the most highly effective strategy.  In fact, 
some successful reports with respect to the therapy for intractable disease such as cancer 
and virus disease have been published [3-6].  However, the efficient and safe siRNA 
delivery systems are required to achieve the desired RNAi effect.  Some common 
siRNA delivery methods are known to be the use of viral and non-viral carriers, and the 
latter has been widely used due to easy preparation of carrier/nucleic acid complexes, 
low cytotoxicity, and lack of immunogenicity.  Generally, chemically unmodified 
siRNAs are rapidly degraded in serum, and it is difficult for them to enter mammalian 
cells.  Thus, the strategies to deliver siRNA to target cells in cell culture include 
physical or chemical transfection [7-9].  
We previously reported that the starburst polyamidoamine (PAMAM) dendrimer 
(dendrimer, generation 3, G3) conjugate with α-cyclodextrin (α-CyD) having an 
average degree of substitution of 2.4 (α-CDE) provided remarkable aspects as a gene 
delivery carrier [10].  α-CDE has some advantages for gene delivery: 1) efficient gene 
transfer activity into mammalian cells and 2) extremely low cytotoxicity at even high 
charge ratios of α-CDE/pDNA.  Therefore, these preferable properties of α-CDE 
recommend it as a new candidate of a novel carrier for siRNA. 
To evaluate the efficiency of the siRNA carrier, the luciferase reporter gene system 
has been widely used.  The system includes the cotransfection system and the 
transfection system: the former system is the method by which the ternary complex of 
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luciferase reporter plasmids with siRNA duplexes and a carrier is transfected and it is 
acknowledged to be useful for simple evaluation of the RNAi effect at the early phase, 
e.g. when it is unclear whether the studied cells are susceptible to RNAi and the 
employed carrier is efficient [11,12].  Meanwhile, the widespread use of the 
transfection system using the binary complex of siRNA/carrier from a basic research 
field to clinical field has been known.  
 In the present study, we firstly evaluated the potential use of α-CDE as an siRNA 
carrier in the cotransfection system, i.e. we prepared the ternary complex consisting of 
1) pGL3 control vector (pGL3) or pGL2 control vector (pGL2) encoding a firefly 
luciferase, 2) siRNA corresponding to pGL3 (siGL3) or siRNA corresponding to pGL2 
(siGL2) and 3) carrier.  Next, we compared the RNAi effects of the ternary complex 
including α-CDE to those of commercial lipid-based transfection reagents such as 
LipofectamineTM2000 (L2), TransFastTM (TF) and LipofectinTM (LF).  Additionally, to 
gain insight into the mechanism for efficient siRNA transfer activity of α-CDE, the 
physicochemical properties of the ternary complex systems and intracellular trafficking 
of siRNA and α-CDE were investigated.  Secondary, we evaluated the potential use of 
α-CDE for an siRNA carrier in the transfection system, the binary complexes of siRNA 
with α-CDE were prepared and the RNAi effects were investigated in the cells.  
 
 
2. Materials and methods 
2.1. Materials 
α-CyD was donated by Nihon Shokuhin Kako (Tokyo, Japan) and recrystallized from 
water.  Dendrimer (G3, ethylenediamine core, molecular weight = 6909) was obtained 
from Aldrich Chemical (Tokyo, Japan).  p-Toluenesulfonyl chloride was purchased 
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from Nacalai Tesque (Kyoto, Japan).  Fetal calf serum (FCS) and Dulbecco’s modified 
Eagle’s medium were purchased from Nichirei (Tokyo, Japan) and Nissui 
Pharmaceuticals (Tokyo, Japan), respectively.  L2 and LF were obtained from 
Invitrogen (Tokyo, Japan).  TF, pGL3 and pGL2 were obtained from Promega (Tokyo, 
Japan).  The pGL2 and pGL3 include both SV40 promoter and enhancer elements to 
produce high levels of luciferase expression, encoding firefly luciferase.  siRNAs and 
fluorescein isothiocyanaye-labeled siGL3 (FITC-siGL3) were obtained from B-Bridge 
(Tokyo, Japan).  Three mismatches between siGL2 and siGL3 sequences are shown in 
an underline below: siGL2 (sense, dTdTGCAUGCGCCUUAUGAAGCU; antisense, 
dTdTAGCUUCAUAAGGCGCAUGC) and siGL3 (sense, 
dTdTGAAUGCGACUCAUGAAGCU; antisense, 
dTdTAGCUUCAUGAGUCGCAUUC).  Tetramethylrhodamine isothiocyanate 
(TRITC) was obtained from Funakoshi (Tokyo, Japan).  The purification of pDNA 
amplified in bacteria was carried out using QIAGEN EndoFree plasmid maxi kit (< 0.1 
EU/μg endotoxin, A260/A280 ratio > 1.8, Tokyo, Japan).  Other chemicals and solvents 
were of analytical reagent grade.   
 
2.2. Preparation of α-CDE and TRITC-α-CDE 
α-CDE was prepared as previously reported [13].  1H-NMR spectrum of the resulting 
α-CDE was measured and the molar ratio of dendrimer and α-CyD was calculated from 
the peak areas of anomeric proton of α-CyD and ethylene protons of the dendrimer.  
α-CDE (DS 2.4): yield, 18%; 1H-NMR (500 MHz, D2O) δ from TMS) 4.94 (H1, 
α-CyD), 3.86-3.74 (H3, H5, H6, α-CyD), 3.53-3.47 (H2, H4, α-CyD), 3.27-3.13 
(dendrimer methylene), 3.05-2.81 (dendrimer methylene), 2.72-2.51 (dendrimer 
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methylene), 2.36-2.31 (dendrimer methylene).  To prepare TRITC-α-CDE, α-CDE 
dissolved in sodium chloride (0.9% w/v) and TRITC dissolving in dimethyl sulfoxide 
were added into the flask, and then the mixture was stirred at room temperature for 24 h.  
The resulting TRITC-α-CDE was purified by dialysis and then precipitated with 
methanol.  
 
2.3. Transfection 
The protocol described below is based on a published procedure [11,12].  NIH3T3 
cells, a mouse fibroblast, and A549 cells, a human lung carcinoma, were purchased 
from American Type Culture Collection (Rockville, MD) and K562 cells, a human 
chronic myelogenous leukemia, were obtained from the Institute of Development, 
Aging and Cancer, Tohoku University (Sendai, Japan).  NIH3T3 cells stably 
expressing luciferase gene (NIH3T3-luc cells) were prepared by hygromycin selection 
following the transfection with the pGL3 complex with α-CDE.  In the cotransfection 
system’s experiments, these various cells were transfected with binary complexes of 
pDNA/carrier or ternary complexes of pDNA/siRNA/carrier.  Two micrograms of 
pDNA and 0.7 μg of siRNA duplex were mixed with α-CDE at the charge ratio of 
100/1 (α-CDE/ pDNA), because transfection efficiency is the highest at this ratio in our 
previous study [9].  The lipoplexes of TF/pDNA and LF/pDNA were prepared at the 
charge ratio of 1/1, and that of L2/pDNA was prepared using 2 μg of pDNA and 2 μl of 
L2 according to the manufacture’s protocols.  The charge ratios represent the number 
of terminal nitrogen atoms of α-CDE or that of nitrogen atoms to TF and LF per 
phosphate atoms on the pDNA.  The amount of α-CDE for the complex preparation of 
2 μg pDNA was 189 μg at the charge ratio of 100/1.  The binary (pDNA/carrier) and 
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ternary complexes (pDNA/siRNA/carrier) were then allowed to stand for 15 min at 
room temperature.  The cells (5 x 104/wells) were seeded 24 h before transfection.  
Two hundred microliters of serum-free medium containing the ternary complex were 
added to each well and then incubated at 37°C for 1 h.  The culture medium (200 μl) 
supplemented with 10% (v/v) FCS was added to each well (24 well).  Control 
transfection was performed without siRNA in the same manner described above.  
Following a 24-h incubation, the cells were washed with 0.5 ml of phosphate buffered 
saline (PBS) and then lysed using Cell Culture Lysis Reagent (Promega, Tokyo, Japan).  
The cell lysates were centrifuged, and then the resulting supernatant was assayed for 
firefly luciferase activity using a Luciferase assay system (Promega, Tokyo, Japan) on a 
luminometer (Lumat LB9506, EG6GBerthold Japan, Tokyo, Japan) and expressed in 
relative light units (RLU)  Protein concentrations were determined using a 
Bicinchoninic acid assay (BCA protein assay kit, Pierce, IL).  It was confirmed that 
α-CyD and α-CDE have no influence on the luciferase assay under the experimental 
conditions.  In the transfection system of siRNA, the binary complexes of 
pDNA/α-CDE and/or siRNA/carrier at the same amount as those of the ternary complex 
were prepared as described above.  NIH3T3 cells (5 x 104/wells) were transfected with 
the binary complex of siRNA/α-CDE 1 h after transfection with the binary complex of 
pDNA/α-CDE, and then the cells were incubated for 24 h, followed by the 
determination of luciferase activity as described above.  In the case of NIH3T3-luc 
cells, the cells were transfected with the binary complex of siRNA/α-CDE and were 
incubated for 24 h, followed by the determination of luciferase activity in the same 
manner.  pDNA, siRNA and carrier types, the ratios of carriers to pDNA or siRNA and 
amounts of pDNA and siRNA used in the present studies are summarized in Table 1. 
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2.4. Interaction between pDNA, siRNA and carrier   
Electrophoretic mobility of the ternary complexes of pDNA/siRNA/carrier was 
performed using an agarose gel electrophoresis system.  Various amounts of α-CDE 
were mixed with 0.5 μg of pGL3 and 0.175 μg of siGL3 in Tris-HCl buffer (10 mM, pH 
7.4) at the indicated charge ratios.  Gel electrophoresis was carried out at room 
temperature in TBE buffer (45 mM Tris-borate, 1 mM EDTA, pH 8.0) in 2% (w/v) 
agarose gel including 0.1 μg/ml of ethidium bromide using MupidTM system (Advance, 
Tokyo, Japan) at 100 V for 30 min.  The pDNA and siRNA bands were visualized 
using an UV illuminator (NLMS-20E, UVP, CA). 
 
2.5. Stability assay of siRNA in FCS  
The ternary complexes of pDNA/siRNA/carrier were incubated in the presence of 50% 
FCS at 37˚C for 5 h.  The solutions were extracted with phenol and 
phenol/chloroform/isoamyl alcohol (25:24:1 v/v/v).  Thereafter, siRNA was 
precipitated with ethanol.  After dissolving the pellet with an RNase-free water, the 
sample were analyzed by an agarose gel electrophoresis (3.5%) according to the method 
reported by Minakuchi et al. [14] and visualized by ethidium bromide staining using an 
UV illuminator (NLMS-20E, UVP, CA). 
 
2.6. Physicochemical properties of ternary complexes 
α-CDE solutions at the concentrations of 1 to 100 μg/μl at various charge ratios 
(TF/pGL3 and LF/pGL3) and volume to amount ratios (L2/pGL3) were added to 
Tris-HCl buffer (10 mM, pH 7.4) containing of 2 μg of pGL3 and 0.7 μg of siGL3 (2 μg 
and 0.7 μg, respectively).  The solution was then incubated for 15 min.  The 
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ζ-potential and particle sizes of the ternary complexes of pGL3/siGL3/carrier were 
determined by dynamic light scattering using a Zetasizer Nano ZS (Malvern 
Instruments, Worcestershire, UK).  The measurement range of this apparatus for 
particle sizes was 0.6 nm to 6000 nm.  The measurements were carried out at least in 
triplicates. 
 
2.7. Cytotoxicity 
The cell viability was assayed using a Cell Counting kit (WST-1 method) from Wako 
Pure Chemical Industries (Osaka, Japan) [15,16].  In brief, NIH3T3, A549 and K562 
cells (2 x 105/well) were incubated for 1 h with 50 μl of serum-free medium containing 
ternary complexes of pDNA/siRNA/carrier at the same amounts of pGL3, siRNA and 
carrier as those described in the transfection section.  The culture medium 
supplemented with 10% (v/v) FCS was added to each well, and the cells were incubated 
at 37°C for 24 h.  After washing twice with Hanks’ balanced salt solution (HBSS, pH 
7.4) in order to remove ternary complexes, 100 μl of fresh HBSS (pH 7.4) and 10 μl of 
WST-1 reagent were added to the well and incubated at 37°C for 4 h.  The absorbance 
of the aliquot of the solution was measured at 405 nm, with referring the absorbance at 
630 nm, with a microplate reader (Bio-Rad Model 550, Tokyo, Japan). 
 
2.8. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis 
The transfection of the ternary complexes was performed as described in the 
transfection section.  As a positive control, NIH3T3 cells (5 x 104/wells) were 
stimulated with 50 μg of polyinosinic-cytidylic acid (poly I:C) for 24 h.  The mRNA 
levels of murine interferon-β (IFN-β) and tumor necrosis factor-α (TNF-α) in NIH3T3 
cells transfected were assayed by semiquantitative RT-PCR method.  Total RNA was 
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isolated from NIH3T3 cells following manufacturer’s instructions.  cDNA was 
synthesized using a reverse primer and RevaTra Ace (Toyobo, Tokyo, Japan).  The 
sequences of the forward and reverse primer pairs of β-actin [17], TNF-α [18] and 
IFN-β [19] used were the following: 5’-TTGGCATAGAGGTCTTTACGGA-3’ and 
5’-GCACCACACCTTCTACAATGAG-3’ for murine β-actin; 
5’-CAAAGGGATGAGAAGTTCCCAA-3’ and 
5’-CTCCTGGTATGAGATAGCAAA-3’ for murine TNF-α; 
5’-AAACAATTTCTCCAGCACTG -3’ and 5’- ATTCTGAGGCATCAACTGAC-3’ 
for murine IFN-β. 
 
2.9. Cellular uptake of siRNA 
Cellular uptake of the ternary complex was determined by a flow cytometry.  Two 
micrograms of pDNA and 0.7 μg of FITC-siRNA duplex were mixed with carriers at 
the charge ratio of 100/1 (α-CDE/pDNA) and 1/1 (TF/pDNA and LF/pDNA), and the 
ratio of 1/1 ((the amount of pDNA to the volume of L2).  After transfection with the 
ternary complexes of pDNA/FITC-siRNA/carrier for 1 h in NIH3T3 cells, the cells 
were washed with PBS (pH 7.4) twice and immediately scraped with 1 ml of PBS (pH 
7.4).  The cells were collected and filtered through nylon mesh.  Data were collected 
for 1 x 104 cells on a FACSCalibur flow cytometer using CellQuest software 
(Becton-Dickinson, Mountain View, CA). 
 
2.10. Confocal laser scanning microscopy (CLSM) 
To observe the cellular uptake of siRNA, NIH3T3 cells (2 x 105 cells/dish) were 
incubated with the ternary complexes of pDNA/FITC-siRNA/TRITC-α-CDE and 
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pDNA/FITC-siRNA/L2, TF or LF for 1 h as described in the cellular uptake section.  
After incubation, the cells were rinsed with PBS (pH 7.4) twice and fixed in methanol at 
4˚C for 5 min prior to microscopy.  Cells were observed by confocal microscopy a 
CLSM (Carl Zeiss LSM410, Tokyo, Japan) with an argon of 350-550 nm after fixation.  
 
2.11. Statistical analysis 
Data given are presented as means ± S.E.M. for each group.  Statistical significance of 
mean coefficients for the studies was performed by analysis of variance followed by 
Scheffe’s test.  p-Values for significance were set at 0.05. 
 
3. Results 
3.1. RNAi effect of the ternary complex of pDNA/siRNA/α-CDE 
To investigate the sequence-specific gene silencing effects of the ternary complex of 
pDNA/siRNA/α-CDE, luciferase activity after transfection of the complex was 
determined.  We used the siGL3 and siGL2 siRNA, i.e., siGL3 has three mismatches 
compared with siGL2 [20].  Figure 1A shows luciferase activity after transfection of 
the ternary complex (pDNA/siRNA/α-CDE) at a charge ratio of 100/1 (α-CDE/pDNA) 
and the 0.7 μg of siRNA in NIH3T3 cells.  As shown in Fig. 1A, the 
pGL3/siGL3/α-CDE complex impaired luciferase activity to approximately 22 % of 
control level (pGL3/α-CDE), but the pGL3/siGL2/α-CDE complex did not.  Likewise, 
the ternary complex of pGL2/siGL2/α-CDE also showed the sequence-specific gene 
silencing effects (53% inhibition of control level) (Fig. 1B).  
Next, we examined the influence of the siRNA concentration on the gene silencing 
effect.  The gene silencing effects of pGL3/siGL3/α-CDE augmented as the amount of 
siRNA increased, and reached a plateau at concentrations greater than 0.5 μg of siRNA 
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(Fig. 1C).  However, no gene silencing effects of the ternary complex of 
pGL3/siGL2/α-CDE were observed.  These results indicate that α-CDE enhances the 
RNAi effect of the ternary complex of pGL3/siGL3/α-CDE. 
We have reported that the binary complex of pDNA/α-CDE augments transfection 
efficiency as the charge ratio (carrier/pDNA) increased [10].  Therefore, the effects of 
the charge ratio (α-CDE/pDNA) on the inhibitory effects of the ternary complex of 
pDNA/siGL3/α-CDE were examined in NIH3T3 cells.  In addition, the ternary 
complex of pGL3/siGL3/α-CDE decreased luciferase activity, although luciferase 
activity increased as the charge ratio of α-CDE/pGL3 complex increased (Fig. 1D).  
However, the extent of the gene silencing effects of the α-CDE complex at the dose of 
0.7 μg and at the charge ratio of 100:1 (α-CDE/pDNA) were approximately 23% and 
27% in Fig. 1C and Fig. 1D, respectively.  Hence, the gene silencing effects of α-CDE 
complex in Fig. 1C and Fig. 1D were slightly lower than that as shown in Fig. 1A, 
possibly due to experimental error.  These results indicate that the charge ratio in the 
ternary complex affects the gene silencing effect of siRNA.   
 
3.2. Comparison of RNAi effect between α-CDE system and commercial transfection 
reagent system 
A number of experimental approaches applying to that of commercial transfection 
reagents for siRNA delivery have been described [21,22].  Among them, the 
widespread use of cationic lipids is well-known [23-25].  Therefore, we compared the 
effect of α-CDE on siRNA-mediated gene silencing with those of the commercial 
transfection reagents such as L2, TF and LF.  As shown in Figs. 2A-D, the ternary 
complex of pGL3/siGL3 with commercial transfection reagents decreased luciferase 
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activity, but these inhibitory effects were somewhat variable and sequence-nonspecific, 
compared with the α-CDE system.  However, the gene-silencing effect was hard to 
compare among the various carrier systems, because luciferase activity in the control 
system (pDNA/carrier) was too variable among the carrier systems.  To normalize the 
RNAi effects among these carrier systems, we calculated the inhibition ratio, which is 
the inhibitory percent in the pGL3/siGL3/carrier system to that in the 
pGL3/siGL2/carrier system (siGL3/siGL2) according to the method reported by Layzer 
et al. [26], and the coefficient of variation (CV) of luciferase activity in the siGL3 
ternary complex system (Figs. 2E, F).  Of these systems, the α-CDE system was found 
to show the highest inhibition ratio and the lowest CV value, indicating the most 
prominent RNAi effect of the α-CDE system.  In addition, similar results were 
observed in the pGL2 control vector system (data not shown).  These results suggest 
that the ternary complex of pDNA/siRNA/α-CDE could be used to provide a more 
potent RNAi effect than those of commercial transfection reagents.   
Generally, the different cell types require different adequate transfection conditions to 
obtain the optimal RNAi effect.  To study the RNAi effect in various cell lines 
(NIH3T3, A549 and K562 cells), we calculated the inhibition ratio.  The 
pGL3/siGL3/α-CDE ternary complex elicited comparable or more efficient gene 
silencing effect, compared to those of commercial transfection reagents in all of the cell 
lines, especially in NIH3T3 cells (Fig. 2G).  These results suggest that the α-CDE 
system provides the prominent RNAi effects. 
  It is important to note whether the gene silencing effects were based on siRNA itself, 
rather than cytotoxicity.  Some reports demonstrate that L2 showed potent cytotoxicity 
even though it provided greatly increased gene transfer activity [27,28].  Thus, we 
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examined cytotoxicity of the ternary complex in various cell lines by the WST-1 
method (Figs. 3A-C).  The ternary complex of pDNA/siRNA/α-CDE showed 
negligible cytotoxicity on NIH3T3 cells below charge ratios of 100/1 (α-CDE/pGL3), 
although it elicited cytotoxicity at more than the charge ratio.  In sharp contrast, the 
commercial transfection reagents elicited cytotoxicity at the charge ratio of 1/1 
(TF/pGL3, LF/pGL3) and the volume to amount ratio of 1/1 (L2/pGL3), and the 
cytotoxicity became more severe at their ratios of 2 (transfection reagents/pGL3) under 
the present experimental conditions (Fig. 3A).  Similar results were observed in A549 
cells (Fig. 3B) and K562 cells (Fig. 3C).  These results suggest that the invariable 
RNAi effect in the commercial transfection reagent systems may be involved, at least in 
part, in their cytotoxicity.  In addition, IFN-β and TNF-α mRNA were not observed in 
NIH3T3 cells transfected with the various ternary complexes (Fig. 3B), although these 
obvious bands were observed by the treatment with polyI:C.  These results suggest no 
interferon response under the present experimental conditions. 
 
3.3. Physicochemical properties of the ternary complexes 
To gain insight into the mechanism for the prominent siRNA transfer activity of α-CDE, 
we investigated the physicochemical properties of the ternary complexes.  First, we 
performed the gel mobility assay to reveal the interaction among carrier, pDNA and 
siRNA.  As shown in Fig. 4A, the bands derived from pDNA and siRNA disappeared 
at a charge ratio of approximately 1/1 (α-CDE/pDNA).  Likewise, the bands derived 
from pDNA and siRNA were observed in the commercial transfection reagent systems 
at a charge ratio (TF/pDNA and LF/pDNA) or an amount to volume ratio (L2/pDNA) of 
1/1 under the experimental conditions (Fig. 4B).  These results suggest that α-CDE 
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forms the complexes with both pDNA and siRNA. 
To test the difference in the interaction of pDNA/siRNA/α-CDE from the 
pDNA/siRNA complex and the commercial transfection reagents, we determined the 
particle sizes and ζ-potential values of the ternary complexes.  The α-CDE system 
provided the mean diameter of 140 nm at the charge ratio of 100/1 (α-CDE/pGL3), and 
the TF system at the charge ratio of 1/1 (TF/pGL3) and the L2 system at the volume to 
amount ratio of 1/1 (L2/pGL3) had the largest and the smallest particle sizes among 
these carrier systems, respectively (Table 2).  On the other hand, the α-CDE system 
and the commercial transfection reagent systems provided positive and negative 
ζ-potential, respectively, although these carriers alone gave positive ζ-potential (Table 
2) at these ratios of 1/1.  In addition, ζ-potentials of the TF and LF systems and the L2 
system turned the negative values to positive values between the charge ratios and the 
volume to amount ratios of 2/1 and 5/1, respectively (Table 2).  However, all of the 
pDNA complexes with TF, LF and L2 showed severe cytotoxicity even at these ratios 
as shown in Fig. 3.  Therefore, we could not compare the RNAi effects of the α-CDE 
complex to those of the TF, LF and L2 complexes having the positive ζ-potentials 
because of their cytotoxicity.  Anyhow, these results suggest the different interaction 
modes between the α-CDE system and the commercially transfection reagents.  
Moreover, the particle sizes of the pDNA complexes with TF, LF and L2 at the charge 
ratio of 5/1 (TF/pGL3 and LF/pGL3) and the volume to amount ratio of 5/1 (L2/pGL3) 
having the positive ζ-potential values were much higher than those at the charge ratio and 
the volume to amount ratio of 1/1 (Table 2).  These results indicate that the charge ratios 
of 2/1 and 5/1 (TF/pGL3 and LF/pGL3) and the volume to amount ratios of 2/1 and 5/1 
(L2/pGL3) are not likely to be the optimal experimental conditions.   
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  siRNA is known to be rapidly degraded by RNase and/or bound to serum albumin.  
Thus, we examined the enzymatic stability of siRNA in the ternary complex (Fig. 4C).  
The degradation of siRNA in the presence of 50% FCS was observed at a charge ratio 
of 1/1 (α-CDE/pGL3), but degradation was suppressed as the charge ratio increased 
(Fig. 4C).  On the other hand, the band derived from siRNA disappeared in the 
commercial transfection reagents at a charge ratio of 1/1 (TF/pGL3 and pLF/pGL3) and 
the volume to amount ratio of 1/1 (L2/pGL3) (Fig. 4C).  These results suggest that 
α-CDE inhibits the degradation of siRNA from RNase in serum because of the stable 
complex formation with pDNA and siRNA.  
 
3.4. Intracellular distribution of siRNA for RNAi effects 
To further gain insight into the mechanism for the prominent RNAi effect of the α-CDE 
system, we examined the cellular uptake of FITC-siGL3 1 h after transfection of the 
ternary complex of pGL3/FITC-siGL3/α-CDE in NIH3T3 cells by a flow cytometric 
analysis (Fig. 5).  The cellular uptake of FITC-siGL3 was the highest in the TF system, 
whereas the α-CDE system was similar to the L2 system.   
Next, we investigated the intracellular localization of FITC-siGL3 and 
TRITC-α-CDE using a CLSM (Fig. 6A).  TRITC-α-CDE and FITC-siGL3 were 
observed in cytoplasm, indicating that α-CDE allowed siRNA to distribute in cytoplasm 
after the cellular uptake into NIH3T3 cells.  Among the carriers used in this study, the 
TF system demonstrated the strongest intracellular fluorescence intensity (Fig. 6B), 
consistent with the results from a flow cytometric analysis (Fig. 5).  In sharp contrast, 
the ternary complex systems of L2 and TF indicated a high localization of FITC-siGL3 
in the nucleus (Fig. 6B).  These findings suggest that the invariable RNAi effects of 
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the α-CDE complex were caused by the delivery of siRNA to cytoplasm, but not 
nucleus. 
 
3.5. RNAi effect of siRNA/α-CDE binary complex 
To test the RNAi effect of binary complexes of siRNA/α-CDE, luciferase activity was 
determined in NIH3T3 cells transiently and stably expressing pGL3 luciferase gene.  
Here, we used the binary complex with the charge ratio of 20/1 (α-CDE/siRNA) 
because this charge ratio provided the maximal RNAi effect in our preliminary 
experiments.  As shown in Fig. 7A, the siGL3/α-CDE binary complex markedly 
suppressed luciferase activity in the cells transiently expressing the gene, but that of 
siGL2/α-CDE complex did not.  Likewise, the sequence-specific suppressing effect of 
siGL3/α-CDE complex was observed in NIH3T3-luc cells stably expressing the gene 
(Fig. 7B).  These results suggest that α-CDE is the promising carrier for the binary 
complex with siRNA as well. 
 
4. Discussion 
In this study, we clarified the potential use of α-CDE as a siRNA carrier compared to 
the commercial transfection reagents because of the sequence-specific and the 
invariable RNAi effect in the ternary complexes of pDNA/siRNA/α-CDE.  In addition, 
the potent RNAi effects among carriers used in the present study could be due to the 
preferable physicochemical properties of the ternary complex and the intracellular 
distribution of the complex in cytoplasm.  Notably, α-CDE was found to elicit the 
RNAi effect in the binary complex system as well. 
In the present study we first used the ternary complex system.  This system is 
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known to be useful for the simple evaluation of the RNAi effect.  Here we prepared the 
binary and ternary complexes at the charge ratio of 100/1 (α-CDE/pDNA) because the 
charge ratio was optimal for gene transfer activity, suggesting that α-CDE in a free form 
may assist in the transfection as reported previously [13].  On the other hand, we 
compared the siRNA transfer activity of α-CDE to commercial transfection reagents 
such as L2, TF and LF under the optimal conditions as recommended by manufacturers, 
because these lipid-based reagents were commonly used as a non-viral carrier for RNAi, 
especially L2 is known to have greatly high transfer activity for gene and siRNA 
[11,29].  However, luciferase activity of the control (the binary complex of 
pDNA/carrier) was not comparable among the various ternary complexes.  In fact, the 
pGL3/α-CDE binary complex had the highest luciferase activity among all of the 
complexes used here in various cells, indicating the most efficient gene transfer activity 
of α-CDE (Fig. 2A-D).  For the comparison of these RNAi effects, thereby, the 
inhibition ratio (inhibitory percent of siGL3 to that of siGL2) and the CV values of the 
inhibitory percent of the ternary complex of pGL3/siGL3/carriers were calculated.  
Under the present conditions, it should be noted that the highest inhibition ratio and the 
lowest CV value were shown in the α-CDE system, despite the α-CDE system having 
the highest luciferase activity.  Thus, it is evident that the ternary complex of 
pDNA/siRNA/α-CDE provided a preferable RNAi effect to those of L2, TF and LF.   
Physicochemical properties of the pDNA complex with α-CDE could be related to 
the RNAi effect.  α-CDE was found to form complex with nucleic acids at low charge 
ratios (Fig. 4), whereas the commercial transfection reagents did not.  In addition, the 
ternary complexes of α-CDE had positive ζ-potential at a charge ratio of 100/1 
(α-CDE/pDNA), but those of commercial transfection reagents showed negative 
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ζ-potential at the charge ratios of 1/1 and 2/1 (TF/pGL3 and LF/pGL3) and the volume 
to amount ratios of 1/1 and 2/1 (L2/pGL3) under the present experimental conditions, 
although these ζ-potentials turned the negative values to the positive values between 
these ratios of 2/1 and 10/1 with changing to larger particle sizes of these complexes 
(Table 2).  Besides, α-CDE was found to abrogate siRNA degradation in the presence 
of 50% FCS, compared to L2, TF and LF (Fig. 4C).  Taken together, these results 
seem to show that α-CDE forms more preferable ternary complex with pDNA and 
siRNA, possibly leading to more efficient RNAi effects of the α-CDE system.  
However, it is still unclear whether the binary complexes of pDNA/α-CDE and/or 
siRNA/α-CDE are included in the ternary complex of pDNA/siRNA/α-CDE.  
Elaborate study is further required to clarify the complex mode.  
The mechanism for the enhanced RNAi effect of the ternary complex of 
pDNA/siRNA/α-CDE may also involve the intracellular distribution of FITC-siRNA 
and TRITC-α-CDE in cytoplasm.  Interestingly, the different intracellular distribution 
of FITC-siRNA was observed among carriers used in this study (Figs. 5, 6).  α-CDE 
allowed siRNA to disperse in cytoplasm, but did not translocate into nucleus.  
Likewise, TRITC-α-CDE was found to distribute into cytoplasm and to colocalize with 
FITC-siGL3 (Fig. 6A).  In sharp contrast, L2 and TF provided the different 
intracellular distribution of siRNA, i.e., the high amounts of siRNAs were localized in 
both the nucleus and cytoplasm.  Hence, these results imply that α-CDE enhances the 
release of siRNA from the endosomal compartment after the cellular uptake of the 
pDNA/α-CDE complex into NIH3T3 cells as reported previously.  These different 
intracellular distribution could be ascribed to their constituents of carriers, that is, 
polymer-based and lipid-based carriers.  However, the luciferase activity after 
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transfection of the binary pDNA complex of α-CDE was higher than that of the pDNA 
complexes of the other transfection reagents (Fig. 1), nevertheless the confocal laser 
microscopic study demonstrated that the ternary complex of α-CDE is unlikely to enter 
the nucleus.  This contradiction may be explained by the low sensitivity of 
TRITC-α-CDE in the nucleus: only a slight difference in the extent of pDNA 
complexes in nucleus may changed luciferase activity.  Meanwhile, the RNA-induced 
silencing complex (RISC) is acknowledged to localize in cytoplasm [30].  Thereby, 
nuclear translocation of siRNA observed in the L2 and TF systems may result in 
undesirable RNAi effects.   
The ternary complex of pGL3/siGL3/α-CDE provided neither cytotoxicity nor 
interferon response (Fig. 3), leading to the preferable RNAi effect.  Meanwhile, the 
ternary complex including L2, TF or LF elicited cytotoxicity (Fig. 3), which results in 
impairment of the RNAi effect.  Unfortunately, we have never evaluated the systemic 
cytotoxicity or the uptake into reticuloendothelial system after intravenous 
administration of the isotonic solution containing the pGL3/siGL3/α-CDE complexes.  
Given the ternary complexes of pDNA/siRNA/α-CDE are going to be applied in vivo, 
the systemic administration of the complex at the high charge ratio (100/1) might 
experience the side effects because of high ζ-potential value.  If so, it is likely that the 
ternary complexes with TF, LF and L2 having low charge ratios compared to the 
complex with α-CDE might be appropriate.  Thereafter, the in vivo study should be 
required to address this pivotal issue. 
In addition to the ternary complex system, we prepared the binary complexes with 
siRNA and evaluated the potential use of α-CDE for a siRNA carrier.  As a result, we 
revealed that luciferase activity significantly decreased after transfection of binary 
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complexes of siGL3/α-CDE in NIH3T3 cells both transiently expressing and stably 
expressing pGL3-derived luciferase gene without cytotoxicity (Fig. 7).  Now, the 
RNAi effect of the siRNA/α-CDE binary complex on endogenous genes such as Lamin 
and Fas is under investigation. 
 
5. Conclusion  
Our findings provided that 1) the α-CDE systems elicited the siRNA-mediated gene 
silencing and the invariable RNAi effects compared to the commercial transfection 
reagent system and 2) the mechanism for the prominent RNAi effects of the ternary 
complex may be involved in the stable complex formation of α-CDE with pDNA and 
siRNA, low cytotoxicity of the α-CDE complexes, the different intracellular 
distribution of siRNA.  3) The binary complex of siRNA/α-CDE provided the 
significant RNAi effect in NIH3T3 cells transiently and stable expressing luciferase 
gene.  Thus, α-CDE could be a new candidate for a siRNA carrier. 
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Figure legends 
Figure 1. (A, B) Sequence-specific gene-silencing effect on luciferase activity in 
NIH3T3 cells transfected with the ternary complexes of pGL3/siRNA/α-CDE (A) and 
pGL2/siRNA/α-CDE (B).  Luciferase activity in cell lysates was determined 24 h after 
incubation with ternary complex.  The amounts of pDNA and siRNA were 2 μg and 
0.7 μg, respectively.  The charge ratio of α-CDE/pDNA was 100/1.  (A) Open 
column, pGL3/α-CDE; closed column, pGL3/siGL2/ α-CDE; light hatched column, 
pGL3/siGL3/ α-CDE.  Each value represents the mean ± S.E.M of 4 experiments.  
*p<0.05, compared with control.  †p<0.05, compared with siGL2.  (B) Open column, 
pGL2/α-CDE; closed column, pGL2/siGL2/α-CDE; light hatched column, 
pGL2/siGL3/ α-CDE.  Each value represents the mean ± S.E.M of 4 experiments.  
*p<0.05, compared with control.  ‡p<0.05, compared with siGL3.  (C) Effects of 
siRNA concentration on RNAi effects of the ternary complex of pGL3/siRNA/α-CDE 
in NIH3T3 Cells.  Open circle; pGL3/siGL3/α-CDE, closed circle; with 
pGL3/siGL2/α-CDE.  Each value represents the mean ± S.E.M of 4 experiments. 
*p<0.05, compared with siGL2.  (D) Effects of charge ratio (α-CDE/pDNA) on 
luciferase activity in NIH3T3 cells transfected with the ternary complexes of 
pGL3/siRNA/α-CDE.  The amounts of pGL3 and siRNA were 2.0 μg and 0.7 μg, 
respectively.  Open circle, pGL3/siGL3/α-CDE; closed circle, pGL3/α-CDE.  Each 
point represents the mean ± S.E.M of 4 experiments.  *p<0.05, compared with control. 
 
Figure 2.  (A-D) Comparison of RNAi effects of siGL3 among various carriers in 
NIH3T3 cells transfected with ternary complexes with pGL3/siGL3/carriers.  The 
RLU relevant to luciferase gene expression and the total protein contents were 
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determined by luciferase assay and Bicinchoninic acid assay, respectively.  Each value 
represents the mean ± S.E.M of 4 experiments.  *p<0.05, compared with control.  
†p<0.05, compared with siGL2.  (E) Comparison of variation of RNAi effects of siGL3 
among various carriers in NIH3T3 cells transfected with ternary complexes with 
pGL3/siGL3/carriers.  The coefficient of variation (CV) stands for the variability of 
the RNAi effect.  Each value represents the mean ± S.E.M of 4 experiments.  *p<0.05, 
compared with α-CDE system.  (F) Comparison of sequence specific RNAi effects of 
siGL3 among various carriers in NIH3T3 cells transfected with ternary complexes with 
pGL3/siGL3/carriers.  The inhibition ratio (siGL3/siGL2) stands for the inhibitory 
effect of the siGL3 system to that of the siGL2 system.  Each value represents the 
mean ± S.E.M of 4 experiments.  *p<0.05, compared with α-CDE system.  (G) 
Sequence-specific RNAi effects of the ternary complexes of pGL3/siRNA/carrier on 
luciferase activity in various cells transfected with the ternary complexes with 
pGL3/siRNA/carriers.  Open column, α-CDE system; closed column, L2 system; light 
hatched column, TF system; dot column; LF system.  Each value represents the mean 
± S.E.M of 4 experiments.  *p<0.05, compared with α-CDE system. 
 
Figure 3.  (A, B, C) Cytotoxicity of the ternary complexes of pGL3/siGL3/carriers in 
various cells.  The cell viability was assayed by the WST-1 method.  Open column, 
α-CDE system; closed column, L2 system; light hatched column, TF system; dot 
column; LF system.  (A), NIH3T3 cells; (B) A549 cells; (C), K562 cells.  a) 
represents the charge ratio and the ratio of the volume of L2 to the amount of pGL3.  
The charge ratios of α-CDE/pGL3 were in the range of 1 to 400.  The charge ratios of 
L2 and TF were 1/1 and 1/2, and the ratio of the volume of L2 to the amount of pGL3 
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was 1/1 and 2/1.  Each point represents the mean ± S.E.M of 4 experiments.  *p<0.05, 
compared with α-CDE system.  (D) Effects of various carriers on IFN-β and TNF-α 
mRNA levels in NIH3T3 cells transfected with the ternary complexes of 
pGL3/siGL3/carriers.  As a positive control, NIH3T3 cells were stimulated with poly 
I:C.  IFN-β and TNF-α mRNA in the cells were determined by semiquantitative 
RT-PCR.  These figures show representative data for three experiments. 
 
Figure 4.  Agarose gel electrophoretic analysis of the ternary complexes of 
pGL3/siGL3/carriers.  (A) Effects of charge ratio on the electrophoretic mobility of 
pGL3 and siGL3.  (B) Effects of carriers on the electrophoretic mobility of pGL3 and 
siGL3.  (C) Stability of siRNA in the ternary complexes of pGL3/siGL3/carriers after 
treated with 50% FCS for 5 h at 37˚C.  In these experiments, the amounts of pDNA 
and siRNA were 0.5 μg and 0.175 μg, respectively.  The charge ratios of 
α-CDE/pGL3, TF/pGL3 and LF/pGL3 were 100/1, 1/1 and 1/1, respectively.  The 
ratio of the amount of pGL3 to the volume of L2 was 1/1.  
 
Figure 5.  Cellular uptake of the ternary complexes of pGL3/FITC-siGL3/carriers in 
NIH3T3 cells after transfection.  After transfection for 1 h, the cells were washed with 
PBS twice and immediately scraped with 1 ml of PBS.  The cells were collected and 
filtered through nylon mesh.  Data were collected for 1 x 104 cells on a FACSCalibur 
flow cytometer using CellQuest software.  (A), pGL3/FITC-siGL3/α-CDE; (B), 
pGL3/FITC-siGL3/L2; (C), pGL3/FITC-siGL3/TF; (D), pGL3/FITC-siGL3/LF.  The 
charge ratios of α-CDE/pGL3, TF/pGL3 and LF/pGL3 were 100/1, 1/1 and 1/1, 
respectively.  The ratio of the amount of pGL3 to the volume of L2 was 1/1.  These 
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figures show representative data for three experiments.   
 
Figure 6. (A) Intracellular distribution of the ternary complex of 
pGL3/FITC-siGL3/TRITC-α-CDE in NIH3T3 cells transfected with the ternary 
complex.  The cells were transfected for 1 h.  After washed twice with PBS, the cells 
were fixed with methanol for 5 min at 4˚C, and then the cells were scanned with a 
CLSM.  The charge ratio of 100/1 (α-CDE/pGL3) was used.  The amounts of pDNA 
and siRNA were 2 μg and 0.7 μg, respectively.  (B) Comparison of intracellular 
distribution of FITC-siGL3 in NIH3T3 cells transfected with the ternary complex of 
pGL3/FITC-siGL3/carriers.  The cells were transfected for 1 h.  After washed twice 
with PBS, the cells were fixed with methanol for 5 min at 4˚C, and then the cells were 
scanned with a CLSM.  The charge ratios of α-CDE/pGL3, TF/pGL3 and LF/pGL3 
were 1/100, 1/1 and 1/1, respectively.  The ratio of the amount of pGL3 to the volume 
of L2 was 1/1.  Arrowhead indicates FITC-siGL3 in the nucleus.  These figures show 
representative data for three experiments.   
 
Figure 7.  (A) Inhibitory effects of post-transfection of the binary complex of 
α-CDE/siGL3 on luciferase activity in NIH3T3 cells transiently expressing luciferase 
gene.  NIH3T3 cells were transfected with pGL3/α-CDE complex 1 h before 
transfection of siRNA alone or the binary complex of α-CDE/siRNA.  The control 
systems represent without siGL3 or α-CDE (open column) and with α-CDE in the 
absence of siGL3 (closed column), respectively.  Open column, siRNA alone; closed 
column, α-CDE/siRNA complex.  The charge ratio of α-CDE/siRNA was 20/1.  The 
siRNA concentration was 100 nM.  Each value represents the mean ± S.E.M. of 4 
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experiments .  *p<0.05, compared with control.  †p<0.05, compared with siGL2.  
(B) Inhibitory effects of the binary complex of α-CDE/siRNA on luciferase activity in 
cells stably expressing pGL3 luciferase gene (NIH3T3-luc).  Luciferase activity in cell 
lysates was determined 24 h after incubation with binary complex.  The control system 
represents α-CDE without siRNA.  The charge ratio of α-CDE/siRNA was 20/1.  The 
siRNA concentration was 100 nM.  Each value represents the mean ± S.E.M of 4 
experiments.  *p < 0.05, compared with control.   †p < 0.05, compared with siGL2. 
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